Search hospitals > New York > New York
NYU Langone Health
Claim this profileNew York, New York 10016
Global Leader in Lung Cancer
Global Leader in Cancer
Conducts research for Breast Cancer
Conducts research for Solid Tumors
Conducts research for Alzheimer's Disease
658 reported clinical trials
260 medical researchers
Summary
NYU Langone Health is a medical facility located in New York, New York. This center is recognized for care of Lung Cancer, Cancer, Breast Cancer, Solid Tumors, Alzheimer's Disease and other specialties. NYU Langone Health is involved with conducting 658 clinical trials across 1,712 conditions. There are 260 research doctors associated with this hospital, such as Sharon L. Gardner, Bhavana Pothuri, Paul Oberstein, MD, and Vamsidhar Velcheti, MD.Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
EGFR positive
2Cancer
Global LeaderStage IV
Stage III
FGFR3 positive
Top PIs
Sharon L. GardnerLaura and Isaac Perlmutter Cancer Center at NYU Langone8 years of reported clinical research
Expert in Brain Tumor
Studies Brain Cancer
33 reported clinical trials
83 drugs studied
Bhavana PothuriLaura and Isaac Perlmutter Cancer Center at NYU Langone2 years of reported clinical research
Expert in Ovarian Cancer
Studies Endometrial Cancer
21 reported clinical trials
33 drugs studied
Paul Oberstein, MDNYU Langone Health3 years of reported clinical research
Expert in Pancreatic Cancer
Studies Colorectal Cancer
21 reported clinical trials
49 drugs studied
Vamsidhar Velcheti, MDLaura and Isaac Perlmutter Cancer Center at NYU Langone2 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
19 reported clinical trials
32 drugs studied
Clinical Trials running at NYU Langone Health
Lung Cancer
Non-Small Cell Lung Cancer
Colorectal Cancer
Lazy Eye
Breast Cancer
Melanoma
Deep Vein Thrombosis
Epilepsy
Smoking
Pancreatic Insufficiency
Surgery vs Stereotactic Ablative Radiotherapy
for Lung Cancer
To Determine if SAbR improves survival over SR in High Risk Operable Stage I NSCLC
Recruiting2 awards Phase 312 criteria
MYTX-011
for Lung Cancer
This trial is testing MYTX-011, a new medication that targets advanced lung cancer cells with specific genetic markers. It uses an antibody to guide a powerful drug directly to the cancer cells to kill them.
Recruiting1 award Phase 19 criteria
A2B395 CAR T-Cell Therapy
for Colorectal Cancer
The goal of this study is to test A2B395, an allogeneic logic-gated Tmod™ CAR T-cell product in subjects with solid tumors including colorectal cancer (CRC), non-small cell lung cancer (NSCLC), head and neck squamous cell carcinoma (HNSCC), triple-negative breast cancer (TNBC), renal cell carcinoma (RCC) and other solid tumors that express EGFR and have lost HLA-A\*02 expression. The main questions this study aims to answer are: * Phase 1: What is the recommended dose of A2B395 that is safe for patients * Phase 2: Does the recommended dose of A2B395 kill the solid tumor cells and protect the patient's healthy cells Participants will be required to perform study procedures and assessments, and will also receive the following study treatments: * Enrollment in BASECAMP-1 (NCT04981119) * Preconditioning lymphodepletion (PCLD) regimen * A2B395 Tmod CAR T cells at the assigned dose
Recruiting1 award Phase 1 & 24 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at NYU Langone Health?
Where is NYU Langone Health located?
Who should I call to ask about financial aid or insurance network?
What insurance does NYU Langone Health accept?
What awards or recognition has NYU Langone Health received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.